Holen Sie sich die Stockscreener-App
2.35
2.62%
0.06
Handel nachbörslich:
2.35
Schlusskurs vom Vortag:
$2.29
Offen:
$2.28
24-Stunden-Volumen:
1.57M
Relative Volume:
0.71
Marktkapitalisierung:
$620.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-208.38M
KGV:
-1.9583
EPS:
-1.2
Netto-Cashflow:
$-156.57M
1W Leistung:
+1.29%
1M Leistung:
+23.04%
6M Leistung:
-10.65%
1J Leistung:
-30.47%
1-Tages-Spanne:
$2.25
$2.44
1-Wochen-Bereich:
$2.195
$2.44
52-Wochen-Spanne:
$1.105
$5.00
Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile
Firmenname
Autolus Therapeutics Plc Adr
Sektor
Branche
Telefon
44 20 3829 6230
Adresse
THE MEDIAWORKS, LONDON
Vergleichen Sie AUTL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AUTL
Autolus Therapeutics Plc Adr
|
2.35 | 620.10M | 0 | -208.38M | -156.57M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-18 | Hochstufung | Goldman | Neutral → Buy |
| 2024-11-15 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-03-27 | Fortgesetzt | Wells Fargo | Overweight |
| 2023-03-17 | Eingeleitet | Bryan Garnier | Buy |
| 2021-06-14 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-07-31 | Eingeleitet | JP Morgan | Overweight |
| 2020-07-22 | Eingeleitet | SunTrust | Buy |
| 2020-04-22 | Eingeleitet | Mizuho | Buy |
| 2019-09-23 | Eingeleitet | Needham | Buy |
| 2019-05-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-10-24 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Autolus Therapeutics Plc Adr Aktie (AUTL) Neueste Nachrichten
Closing Figures: Autolus Therapeutics plc ADR (AUTL)’s Negative Finish at 2.05, Down -3.30 - DWinneX
NOV Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com
Autolus shares surge 77% following InvestingPro’s April Fair Value signal By Investing.com - Investing.com India
EMA committee endorses Autolus’ leukemia therapy obe-cel By Investing.com - Investing.com South Africa
Autolus Therapeutics Gets Favorable Recommendation For Approval Of Cancer Therapy In EU: Retail Sentiment Brightens By Stocktwits - Investing.com India
EMA committee endorses Autolus’ leukemia therapy obe-cel - Investing.com
Autolus Therapeutics plc ADR (AUTL) Has A Gold Mine On Its Hands - Stocksregister
Autolus reports $9M in Q1 product revenue, gains UK approval By Investing.com - Investing.com South Africa
Autolus reports $9M in Q1 product revenue, gains UK approval - Investing.com
AUTL’s Market Whiplash: -44.26% YTD Decline, -21.08% Plunge in 30 Days - investchronicle.com
There is no doubt that Autolus Therapeutics plc ADR (AUTL) ticks all the boxes. - Sete News
Autolus Therapeutics plc ADR (AUTL) receives a Buy rating from Goldman - knoxdaily.com
AUTL’s valuation metrics: A comprehensive analysis - uspostnews.com
Market Resilience: Autolus Therapeutics plc ADR (AUTL) Finishes Weak at 1.33, Down -5.00 - DWinneX
Market Update: Goosehead Insurance Inc (GSHD) Sees Positive Movement, Closing at 99.54 - DWinneX
How Do Things Look For Autolus Therapeutics plc ADR (NASDAQ: AUTL) In The Short-Term? - Stocksregister
UK approves Autolus leukemia therapy with conditions By Investing.com - Investing.com India
For Autolus Therapeutics plc ADR [AUTL], Analyst sees a rise to $7.60. What next? - dbtnews.com
UK approves Autolus leukemia therapy with conditions - Investing.com
Autolus Therapeutics plc ADR [NASDAQ: AUTL] Sees Decrease in Stock Value - knoxdaily.com
Market cap of i-80 Gold Corp [IAUX] reaches 279.54M – now what? - dbtnews.com
Daiwa Securities lifts Bilibili Inc ADR [BILI] price estimate. Who else is bullish? - dbtnews.com
Market Watch: Autolus Therapeutics plc ADR (AUTL)’s Noteworthy Gain, Closing at 1.60 - DWinneX
It makes sense and dollars to buy Autolus Therapeutics plc ADR (AUTL) stock - Sete News
How does PROG Holdings Inc (PRG) change from a tortoise to a hare? - Sete News
Investors in cash trouble should check out BBB Foods Inc (TBBB) - Sete News
Take off with Energous Corp (WATT): Get ready for trading - Sete News
The growth track for Protalix BioTherapeutics Inc (PLX) has changed recently - Sete News
Tokio Marine Holdings, Inc. Sponsored ADR (OTCMKTS:TKOMY) Short Interest Update - Defense World
Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - GlobeNewswire Inc.
PSQ Holdings Inc (PSQH) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Truist cuts Autolus stock price target to $10, maintains buy rating By Investing.com - Investing.com South Africa
Truist cuts Autolus stock price target to $10, maintains buy rating - Investing.com India
Agilent tech aids in FDA approval of Autolus CAR T therapy By Investing.com - Investing.com South Africa
Arhaus Inc (NASDAQ: ARHS)’s Stock Adds 0.70%, Making It A Good Investment - Stocks Register
Agilent tech aids in FDA approval of Autolus CAR T therapy - Investing.com UK
Truist maintains $11 target on Autolus stock amid strong demand By Investing.com - Investing.com South Africa
Mizuho maintains $12 target on Autolus stock after Q4 update - Investing.com India
Autolus reports progress in commercial launch and financials By Investing.com - Investing.com South Africa
Truist maintains $11 target on Autolus stock amid strong demand - Investing.com India
Autolus reports progress in commercial launch and financials - Investing.com India
Earnings call transcript: Autolus Therapeutics Q4 2024 earnings and market reaction By Investing.com - Investing.com South Africa
Autolus at Leerink’s Global Healthcare Conference: Strategic Moves in CAR T Therapy - Investing.com
10 Best UK Growth Stocks to Buy Now - Insider Monkey
Stock Surge: Autolus Therapeutics plc ADR (AUTL) Closes at 1.82, Marking a 1.68 Increase/Decrease - The Dwinnex
It would be worthwhile to take a closer look at Autolus Therapeutics plc ADR (AUTL) - US Post News
Perhaps timely catching Autolus Therapeutics plc ADR (AUTL) would be a good idea - SETE News
Autolus Therapeutics plc ADR (AUTL) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Autolus Therapeutics plc ADR [AUTL] Officer makes an insider purchase of 698,741 shares worth 2.96 million. - Knox Daily
Lowe’s Cos., Inc Inc. (LOW) Price Performance: The Role of Supply and Demand - The InvestChronicle
Avinger Inc [AVGR] Records 50-Day SMA of $0.7054 - Knox Daily
Finanzdaten der Autolus Therapeutics Plc Adr-Aktie (AUTL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):